Free Biopharma Stock Content

As we have reached the end of April, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly...

$XBI $73.83 | -3.1% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $MRNA -5.7% Moderna Files to...

$XBI $76.19| +0.36% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $MRNA +0.6% Moderna Files for...

$XBI $75.92| -1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $ Pipeline Updates $SQZ -5.1% SQZ...

$XBI $76.69 | -6% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $PFE BNTX Pfizer and BioNTech Submit...

$XBI $81.57 | +2.17% Covid Updates $GILD +0.64% Veklury® (Remdesivir) is First and Only Approved Treatment for Pediatric Patients Under...

BULL THESIS SUMMARY* HRTX overall corporate and executive summary HRTX has a very high short interest and positive news/momentum, could...

As we have reached the middle of April, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly...

See today's biotech moves in our daily update post including news for NVAX, INCY, SCYX and more!

$XBI $81.16 | -4.3% Covid Updates $NRXP -13.2% NRx Pharmaceuticals Files New Breakthrough Therapy Designation Request for ZYESAMI®...

$XBI $84.79 | +0.22% Covid Updates $AZN +0.8% Evusheld significantly protected against symptomatic COVID-19 for at least six months in...

$XBI $84.60 | +1.21% Covid Updates $MRNA -1.3% Moderna Announces Clinical Update on Bivalent COVID-19 Booster Platform. source $NVAX...

$XBI $83.59 | -4.76% Covid Updates $OCGN -5.8% Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North...

We used our BPIQ pipeline screener (https://www.bpiq.com/pipeline-screener) to identify companies that might be effected by the upcoming...

Summary: Since the COVID-19 pandemic started in 2020, the valuation of many smid-cap biopharma companies with recently approved products...

$XBI $87.77 Pipeline Updates $TGTX TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and...

As we have reached the middle of April, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly...

$XBI $87.77 | -2.92% Covid Updates $PFE 0,0% & -2.3% BNTX Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following...

BULL THESIS SUMMARY CRTX overall corporate and executive summary In a seminal clinical trial, CRTX established proof of concept that...

$XBI $90.41 | +3.8% Covid Updates $NVAX +7.0% Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine. source...